ES417012A2 - Mejoras introducidas en el objeto de la patente principal, num. 399.057. - Google Patents

Mejoras introducidas en el objeto de la patente principal, num. 399.057.

Info

Publication number
ES417012A2
ES417012A2 ES417012A ES417012A ES417012A2 ES 417012 A2 ES417012 A2 ES 417012A2 ES 417012 A ES417012 A ES 417012A ES 417012 A ES417012 A ES 417012A ES 417012 A2 ES417012 A2 ES 417012A2
Authority
ES
Spain
Prior art keywords
atom
compounds
substituted
group
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES417012A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES417012A2 publication Critical patent/ES417012A2/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES417012A 1972-07-19 1973-07-17 Mejoras introducidas en el objeto de la patente principal, num. 399.057. Expired ES417012A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3383472A GB1438940A (en) 1972-07-19 1972-07-19 17beta-haloalkoxycarbonyl-17alpha-oxysteroids

Publications (1)

Publication Number Publication Date
ES417012A2 true ES417012A2 (es) 1976-04-16

Family

ID=10358062

Family Applications (1)

Application Number Title Priority Date Filing Date
ES417012A Expired ES417012A2 (es) 1972-07-19 1973-07-17 Mejoras introducidas en el objeto de la patente principal, num. 399.057.

Country Status (18)

Country Link
US (1) US3856828A (en])
JP (1) JPS5750800B2 (en])
AU (1) AU473714B2 (en])
BE (1) BE802481R (en])
CA (1) CA1034565A (en])
CH (1) CH619968A5 (en])
DE (1) DE2336633A1 (en])
DK (1) DK133158C (en])
ES (1) ES417012A2 (en])
FR (1) FR2192840B2 (en])
GB (1) GB1438940A (en])
IE (1) IE37925B1 (en])
IL (1) IL42779A (en])
LU (1) LU68039A1 (en])
NL (1) NL7309992A (en])
PH (1) PH14795A (en])
SE (1) SE396079B (en])
ZA (1) ZA734896B (en])

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943124A (en) * 1970-12-17 1976-03-09 Gordon Hanley Phillipps Chemical compounds
US3989686A (en) * 1972-06-15 1976-11-02 Glaxo Laboratories Limited Anaesthetic steroids of the androstane series and process for preparing same
US4093721A (en) * 1974-08-30 1978-06-06 Glaxo Laboratories Limited Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
DK118776A (da) * 1975-03-21 1976-09-22 Schering Ag Pregnansyrederivater
CH628355A5 (de) * 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
IT1114534B (it) * 1978-02-08 1986-01-27 Glaxo Group Ltd Steroide anti-infiammatorio della serie dell'androstano composizioni che lo contengono e procedimento per produrlo
US4187301A (en) * 1978-04-05 1980-02-05 Syntex (U.S.A.) Inc. 17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
US4252729A (en) * 1978-05-12 1981-02-24 Hoffmann-La Roche Inc. Steroids and process for their manufacture
FR2477156A1 (fr) * 1980-02-15 1981-09-04 Glaxo Group Ltd Carbothioates d'androstanes, leur procede de preparation, composes pour leur preparation et leur application en therapeutique
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US4710495A (en) * 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
PT73772B (en) * 1980-10-06 1983-10-14 Glaxo Group Ltd Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
EP0334853B1 (en) * 1987-10-13 1993-06-09 BODOR, Nicholas S. Soft steroids having anti-inflammatory activity
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
AU2001276497B2 (en) * 2000-08-05 2005-04-07 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
ES2314052T3 (es) * 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.
GB0125259D0 (en) * 2001-10-20 2001-12-12 Glaxo Group Ltd Novel compounds
WO2003072592A1 (en) * 2002-01-15 2003-09-04 Glaxo Group Limited 17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
WO2003062259A2 (en) * 2002-01-21 2003-07-31 Glaxo Group Limited Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
GB0202216D0 (en) * 2002-01-31 2002-03-20 Glaxo Group Ltd Novel compounds
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0225287D0 (en) * 2002-10-30 2002-12-11 Glaxo Group Ltd Novel compounds
CA2558941C (en) 2003-06-19 2012-05-15 Nicholas S. Bodor Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
GB0316290D0 (en) * 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
US20090124588A1 (en) * 2005-01-10 2009-05-14 Glaxo Group Limited Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
EP1841780B1 (en) * 2005-01-10 2011-07-27 Glaxo Group Limited Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
US20070245924A1 (en) * 2006-04-20 2007-10-25 Hofmann Michael A Reduced abrasion of titanium dioxide pigments produced from the chloride process
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
US9290446B2 (en) 2010-10-27 2016-03-22 Hovione Inter Limited Electrophilic reagents for monohalomethylation, their preparation and their uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
GB1384372A (en) * 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids

Also Published As

Publication number Publication date
BE802481R (fr) 1974-01-18
GB1438940A (en) 1976-06-09
DE2336633A1 (de) 1974-01-31
DK133158B (da) 1976-03-29
US3856828A (en) 1974-12-24
JPS5750800B2 (en]) 1982-10-28
FR2192840A2 (en]) 1974-02-15
SE396079B (sv) 1977-09-05
CA1034565A (en) 1978-07-11
ZA734896B (en) 1974-12-24
IL42779A (en) 1977-04-29
CH619968A5 (en]) 1980-10-31
IE37925B1 (en) 1977-11-09
PH14795A (en) 1981-12-09
IE37925L (en) 1974-01-19
JPS4980058A (en]) 1974-08-02
AU473714B2 (en) 1976-07-01
FR2192840B2 (en]) 1976-12-24
NL7309992A (en]) 1974-01-22
DK133158C (da) 1976-09-06
AU5825273A (en) 1975-01-23
LU68039A1 (en]) 1973-09-26

Similar Documents

Publication Publication Date Title
ES417012A2 (es) Mejoras introducidas en el objeto de la patente principal, num. 399.057.
ES399057A1 (es) Procedimiento para preparar compuestos esteroides que tie- nen propiedades anti-inflamatorias.
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
IE37046L (en) IMIDAZO [5,1-f]-as-TRIAZINES
IE45256L (en) Quinazolone derivatives
GB1464680A (en) Benzoxazine derivatives and herbicidal compositions containing the same
GB1292790A (en) Phenyl derivatives and a process for the manufacture thereof
ATE27817T1 (de) Phenylpiperazin-derivate und verfahren zu deren herstellung.
GB1075251A (en) Cardenolide derivatives
GB1254999A (en) Substituted nitrosalicylanilides and bactericidal and lamprecidal uses thereof
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
ES425175A1 (es) Procedimiento para la preparacion de derivados de acido pregnanico.
GB984022A (en) D-homoandrost-9(11)-ene-18-nitrile derivatives and their preparation
GB1148117A (en) D-homosteroids and process for their manufacture
GB1112840A (en) Steroids having pro-oestrogenic activity
GB1187660A (en) Fluoroformates of Steroid 17-beta-Ols
ES8406442A1 (es) Un procedimiento para preparar compuestos de acido quinolilacetico
IE780262L (en) Carbocyclic fused thiophen-2-oxaminic acid derivatives
GB1352870A (en) Photosensitive compositions
GB1515017A (en) 2',3'-dihydroestra-1,3,5(10)-trieno-(16alpha,17alpha-b)furan-17beta-ols
ES476273A1 (es) Un procedimiento para preparar nuevos analogos de cefalospo-rina
GB1130190A (en) Improvements in or relating to steroid intermediates and the production thereof
GB1455396A (en) 4,-o-sulphonyl-erythromycin-9-o-oxime derivatives
GB1498200A (en) Herbicidally effective 1,3,4-thiadiazolyl-(2)-hexahydrotriazinone derivatives
IE41686L (en) Azidotriazine-amidine derivatives.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170704